Mycoplasma gallisepticum formulation
    1.
    发明申请
    Mycoplasma gallisepticum formulation 审中-公开
    支原体支原体配方

    公开(公告)号:US20060257414A1

    公开(公告)日:2006-11-16

    申请号:US10520833

    申请日:2003-07-10

    Abstract: The present invention provides a protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes. The formulation comprises a protective amount of live MG strain K5054 or derivatives thereof in a pharmaceutically acceptable carrier. A vaccine that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes is also presented. Methods for administering the formulation and vaccine are also presented.

    Abstract translation: 本发明提供一种保护性制剂,其可以防止鸡尾草杆菌中的毒性毒蕈碱性支原体感染。 制剂包含保护量的活MG菌株K5054或其药学上可接受的载体中的衍生物。 还提出了一种能够预防鸡尾草属鸡的毒性支原体感染疫苗。 还提供了施用制剂和疫苗的方法。

    Mycoplasma gallisepticum formulation
    2.
    发明授权
    Mycoplasma gallisepticum formulation 失效
    支原体支原体配方

    公开(公告)号:US07217420B2

    公开(公告)日:2007-05-15

    申请号:US10194180

    申请日:2002-07-13

    Abstract: The present invention provides a protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes. The formulation comprises a protective amount of live MG strain K5054 or derivatives thereof in a pharmaceutically acceptable carrier. A vaccine that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes is also presented. Methods for administering the formulation and vaccine are also presented.

    Abstract translation: 本发明提供一种保护性制剂,其可以防止鸡尾草杆菌中的毒性毒蕈碱性支原体感染。 制剂包含保护量的活MG菌株K5054或其药学上可接受的载体中的衍生物。 还提出了一种能够预防鸡尾草属鸡的毒性支原体感染疫苗。 还提供了施用制剂和疫苗的方法。

Patent Agency Ranking